PLRX
Pliant Therapeutics Inc
Price:  
1.40 
USD
Volume:  
845,339.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PLRX EV/EBITDA

-
Upside

As of 2025-07-11, the EV/EBITDA ratio of Pliant Therapeutics Inc (PLRX) is -0.11. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PLRX's latest enterprise value is 24.29 mil USD. PLRX's TTM EBITDA according to its financial statements is -219.95 mil USD. Dividing these 2 quantities gives us the above PLRX EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples - -
Forward P/E multiples - -
Fair Price - -
Upside - -
1.40 USD
Stock Price
- USD
Fair Price

PLRX EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-07-10 -0.11
2025-07-09 -0.10
2025-07-08 -0.05
2025-07-07 -0.05
2025-07-03 -0.07
2025-07-02 -0.05
2025-07-01 -0.05
2025-06-30 -0.04
2025-06-27 -0.07
2025-06-26 -0.08
2025-06-25 -0.10
2025-06-24 -0.08
2025-06-23 -0.07
2025-06-20 -0.08
2025-06-18 -0.09
2025-06-17 -0.09
2025-06-16 -0.10
2025-06-13 -0.10
2025-06-12 -0.13
2025-06-11 -0.13
2025-06-10 -0.15
2025-06-09 -0.17
2025-06-06 -0.17
2025-06-05 -0.17
2025-06-04 -0.18
2025-06-03 -0.17
2025-06-02 -0.12
2025-05-30 -0.10
2025-05-29 -0.10
2025-05-28 -0.10
2025-05-27 -0.08
2025-05-23 -0.08
2025-05-22 -0.09
2025-05-21 -0.09
2025-05-20 -0.10
2025-05-19 -0.10
2025-05-16 -0.10
2025-05-15 -0.10
2025-05-14 -0.10
2025-05-13 -0.10
2025-05-12 -0.13
2025-05-09 -0.11
2025-05-08 -0.13
2025-05-07 -0.12
2025-05-06 -0.12
2025-05-05 -0.16
2025-05-02 -0.19
2025-05-01 -0.17
2025-04-30 -0.16
2025-04-29 -0.13